Sherry Heldens
Impact in
- Immunology top 2%
- Immune Response and Inflammation
- interferon and immune responses
- IL-33, ST2, and ILC Pathways
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- T-cell and B-cell Immunology 2
- Immune Response and Inflammation 2
- Immunotherapy and Immune Responses 1
-
- Melanoma and MAPK Pathways 1
- Co-authors
- Salina Louie (1 shared paper)Nobuhiko Kayagaki (1 shared paper)Jinfeng Liu (1 shared paper)Merone Roose‐Girma (1 shared paper)Mohamed Lamkanfi (1 shared paper)Kim Newton (1 shared paper)Vishva M. Dixit (2 shared papers)Juan Zhang (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Proceedings of the National Academy of Sciences (1 paper)The Journal of Immunology (1 paper)Current Biology (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
Sherry Heldens
6 papers receiving 3.8k citations
Sherry Heldens's Hit Papers
Peers
Comparison fields: 5 of 107
- Immunology 1.3k
- Nephrology 240
- Molecular Biology 2.3k
- Pulmonary and Respiratory Medicine 912
- Oncology 770
Countries citing papers authored by Sherry Heldens
This map shows the geographic impact of Sherry Heldens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Heldens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Heldens more than expected).
Fields of papers citing papers by Sherry Heldens
This network shows the impact of papers produced by Sherry Heldens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Heldens. The network helps show where Sherry Heldens may publish in the future.
Co-authors
The 25 scholars most cited alongside Sherry Heldens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Non-canonical inflammasome activation targets caspase-11 Hit paper breakdown → | 2011 | 2053 |
| 2 | Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib Hit paper breakdown → | 2005 | 1197 |
| 3 | 2000 | 284 | |
| 4 | 2012 | 158 | |
| 5 | 1999 | 152 | |
| 6 | 2010 | 14 |
About Sherry Heldens
Sherry Heldens is a scholar working on Immunology, Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 6 papers that have together received 3.9k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (2 papers), Immune Response and Inflammation (2 papers), Cancer Mechanisms and Therapy (1 paper), Cell Adhesion Molecules Research (1 paper), NF-κB Signaling Pathways (1 paper), Lung Cancer Treatments and Mutations (1 paper), Immunotherapy and Immune Responses (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Immunology (1.3k citations), Nephrology (240 citations), Molecular Biology (2.3k citations), Pulmonary and Respiratory Medicine (912 citations) and Oncology (770 citations). Sherry Heldens has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Salina Louie, Nobuhiko Kayagaki, Jinfeng Liu, Merone Roose‐Girma, Mohamed Lamkanfi, Kim Newton, Vishva M. Dixit, Juan Zhang, Søren Warming and Yan Qu. Their work appears in journals such as Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, The Journal of Immunology, Current Biology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.